Join StocksJar.com -Get 7 Days Free trial

Revvity (RVTY) Stock Price & AI Analysis

$91.25
-$1.65
(1.78%)
Health Care Equipment

NYSE USA

May 12, 9:02 PM EDT
  • Market Cap.
    10.76B
  • Volume
    1.33M
  • Avg. Volume
    1.20M
  • Target Price
    $118
  • 52W Range
    88.53 - 129.50
  • RSI (14)
    40.42
  • Beta
    1
  • PEG Ratio
    4.69
  • SMA 20
    -2.29%
  • SMA 50
    -10.33%
  • SMA 200
    -20.32%
  • Insider Owner
    0.42%
  • Insider Trans
    -7.65%
  • Institution Owner
    96.85%
  • Institution Trans
    2.62%
  • Short Interest
    5.11%
  • EPS next Y
    11.31

Revvity Company Profile

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

Revvity | Latest news

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds,...

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds,...

Life sciences company Revvity (NYSE:RVTY) reported Q1 CY2025 results beating Wall Street’s revenue...

StockStory - 12 hours ago

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

RVTY expands its alliance with Genomics England to boost newborn genomic sequencing research, aiming...

Zacks - 2 months ago

Revvity (RVTY) to Report Q4 Earnings: What's in the Cards?

Revvity (RVTY) to Report Q4 Earnings: What's in the Cards?

Revvity's (RVTY) fourth-quarter results are likely to reflect weak performance at the Diagnostics...

Zacks - 1 year ago

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Revvity, Inc. RVTY announced the receipt of the FDA’s 510(k) clearance for EUROIMMUN’s automated...

Zacks - 4 months ago

RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up

RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up

Revvity, Inc. RVTY reported first-quarter 2025 adjusted earnings per share (EPS) of $1.01, which...

Zacks - 2 weeks ago

Decoding Revvity Inc (RVTY): A Strategic SWOT Insight

Decoding Revvity Inc (RVTY): A Strategic SWOT Insight

Revvity Inc (NYSE:RVTY) showcases robust growth in the health science solutions sector. Strategic...

GuruFocuscom - 1 year ago

Revvity Inc (RVTY) Reports Q3 2023 Earnings: A Detailed Review

Revvity Inc (RVTY) Reports Q3 2023 Earnings: A Detailed Review

Revvity Inc (NYSE:RVTY) reported a GAAP EPS of $0.08 and adjusted EPS from continuing operations of...

GuruFocuscom - 2 years ago

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

Revvity, Inc. (NYSE:RVTY) received a lot of attention from a substantial price movement on the NYSE...

Simply Wall St - 2 years ago

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few...

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few...

Bretton Capital Management, an investment management company, released “Bretton Fund” fourth quarter...

Insider Monkey - 3 months ago

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and...

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and...

Revvity Inc (RVTY) reports robust Q4 results with 6% organic growth and a 30.3% adjusted operating...

GuruFocuscom - 3 months ago